Jæger, Karoline Horgmo
Edwards, Andrew G.
Giles, Wayne R.
Tveito, Aslak
Funding for this research was provided by:
Norges Forskningsråd (309871/E50, 322312)
Article History
Received: 12 January 2022
Accepted: 12 April 2022
First Online: 29 April 2022
Competing interests
: K.H.J., A.T., and A.G.E. have financial relationships with Organos Inc., and the company may benefit from commercialization of the results of this research. In addition, W.R.G. serve as a Consultant for InCarda Ltd. concerning their efforts to develop new pharmaceutical approaches for AF.